ICOSAVAX, INC. Comprehensive Income
ICOSAVAX, INC. reported Comprehensive Income of -$22.02 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2023-11-14
- ICOSAVAX, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-09-30 was -$22.02M.
- ICOSAVAX, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$26.50M.
- ICOSAVAX, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$24.22M.
- ICOSAVAX, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2022-12-31 was -$23.41M.
- ICOSAVAX, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$92.16M.
- ICOSAVAX, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$66.97M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$22.02M 10-Q · filed 2023-11-14 | -$48.52M derived: sum of 2 quarters · filed 2023-11-14 | -$72.74M 10-Q · filed 2023-11-14 | -$96.15M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | -$26.50M 10-Q · filed 2023-08-14 | -$50.72M 10-Q · filed 2023-08-14 | -$74.13M derived: sum of 3 quarters · filed 2023-08-14 | -$96.44M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | -$24.22M 10-Q · filed 2023-05-10 | -$47.63M derived: sum of 2 quarters · filed 2023-05-10 | -$69.94M derived: sum of 3 quarters · filed 2023-11-14 | -$92.85M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | -$23.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$45.72M derived: sum of 2 quarters · filed 2023-11-14 | -$68.63M derived: sum of 3 quarters · filed 2023-11-14 | -$92.16M 10-K · filed 2023-03-30 |
| 2022-09-30 | -$22.31M 10-Q · filed 2023-11-14 | -$45.22M derived: sum of 2 quarters · filed 2023-11-14 | -$68.75M 10-Q · filed 2023-11-14 | -$86.94M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$22.91M 10-Q · filed 2023-08-14 | -$46.44M 10-Q · filed 2023-08-14 | -$64.63M derived: sum of 3 quarters · filed 2023-08-14 | -$99.01M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$23.53M 10-Q · filed 2023-05-10 | -$41.72M derived: sum of 2 quarters · filed 2023-05-10 | -$76.10M derived: sum of 3 quarters · filed 2023-05-10 | -$84.65M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$18.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$52.57M derived: sum of 2 quarters · filed 2023-03-30 | -$61.12M derived: sum of 3 quarters · filed 2023-03-30 | -$66.97M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$34.39M 10-Q · filed 2022-11-14 | -$42.94M derived: sum of 2 quarters · filed 2022-11-14 | -$48.79M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$8.55M 10-Q · filed 2022-08-15 | -$14.40M 10-Q · filed 2022-08-15 |